Patents by Inventor Mi Sun Ahn

Mi Sun Ahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10039803
    Abstract: The present invention relates to an ophthalmic composition comprising cyclosporine and trehalose as effective components, a method for producing the same, a method for preventing, improving or treating failure caused by ophthalmoxerosis by administering the same, and a use therefor. The ophthalmic composition according to the present invention has a combination of superior effects on ophthalmoxerosis, which can be caused by various factors such as dry air, inflammation, preservatives, etc., and is placed in a variety of states or conditions.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: August 7, 2018
    Assignee: HUONS CO., LTD.
    Inventors: Jong Hwan Lim, Sung-Woon Hong, Dae Woong Ko, Seung Kwan Nam, Mi Sun Ahn, Deok-Kyu Hwang, Yeong-Mok Kim, Key-An Um
  • Publication number: 20170224766
    Abstract: The present invention relates to an ophthalmic composition comprising cyclosporine and trehalose as effective components, a method for producing the same, a method for preventing, improving or treating failure caused by ophthalmoxerosis by administering the same, and a use therefor. The ophthalmic composition according to the present invention has a combination of superior effects on ophthalmoxerosis, which can be caused by various factors such as dry air, inflammation, preservatives, etc., and is placed in a variety of states or conditions.
    Type: Application
    Filed: October 19, 2015
    Publication date: August 10, 2017
    Inventors: Jong Hwan LIM, Sung-Woon HONG, Dae Woong KO, Seung Kwan NAM, Mi Sun AHN, Deok-Kyu HWANG, Yeong-Mok KIM, Key-An UM
  • Patent number: 8519108
    Abstract: The method of the present invention comprising successive column chromatography processes for the purification of an anthrax protective antigen can achieve an improved purity of the anthrax protective antigen product by effectively removing impurities (e.g., cellular residual proteins in the culture solution) without the loss of anthrax protective antigen. Therefore, the method of the present invention can be advantageously used for economically producing the anthrax protective antigen on a large scale.
    Type: Grant
    Filed: January 9, 2009
    Date of Patent: August 27, 2013
    Assignees: Korea Center For Disease Control and Prevention, Green Cross Corporation
    Inventors: Hee-Bok Oh, Bong-Su Kim, Gi-Eun Rhie, Jeong-Hoon Chun, Hun Kim, SinKoo Yeo, MahnHoon Park, Chong-Hwan Jonathan Chang, Mi Sun Ahn
  • Publication number: 20110015377
    Abstract: The method of the present invention comprising successive column chromatography processes for the purification of an anthrax protective antigen can achieve an improved purity of the anthrax protective antigen product by effectively removing impurities (e.g., cellular residual proteins in the culture solution) without the loss of anthrax protective antigen. Therefore, the method of the present invention can be advantageously used for economically producing the anthrax protective antigen on a large scale.
    Type: Application
    Filed: January 9, 2009
    Publication date: January 20, 2011
    Inventors: Hee-Bok Oh, Bong-Su Kim, Gi-Eun Rhie, Jeong-Hoon Chun, Hun Kim, Sinkoo Yeo, Mahnhoon Park, Chong-Hwan Jonathan Chang, Mi Sun Ahn